AusBiotech presents BioPro Professional Development BioPro Course: The Secret Sauce of Deal Making Sponsored by the Government of Victoria

Size: px

Start display at page:

Download "AusBiotech presents BioPro Professional Development BioPro Course: The Secret Sauce of Deal Making Sponsored by the Government of Victoria"

Walter Green
5 years ago
Views:

Monday 29 October 9:00am 5:00pm AusBiotech presents BioPro Professional Development BioPro Course: The Secret Sauce of Deal Making Sponsored by the Government of Victoria Tuesday 30 October 9:00am

1 Monday 29 October 9:00am 5:00pm AusBiotech presents BioPro Professional Development BioPro Course: The Secret Sauce of Deal Making Sponsored by the Government of Victoria Tuesday 30 October 9:00am 5:00pm AusBiotech presents BioPro Professional Development BioPro Course: The Secret Sauce of Deal Making BioBasics: Industry Knowledge for the Non-Scientist BioPro Course: Best Practice Valuation in Biotechnology 1:00pm 2:30pm AusBiotech-GSK Student Excellence Awards Judging Judging Panel: Glenn Cross, Chief Operating Officer, AusBiotech Dr Andrew Yeates, Chief Medical Director, GlaxoSmithKline, Australia Dr Simon Tucker, Vice President Research CSO, Biota Holdings Limited Sponsored by GlaxoSmithKline Australia 1 21/09/2012 Draft Program - subject to change

2 Wednesday 31 October 7:00am 6:00pm 9:00am 11:00am 1:00pm 5:30pm Conference Registration Victorian Government Briefing for International Delegates Venue: Investment Centre, 55 Collins Street, Melbourne BioIndustry Exhibition & Business Matching Open 1:00pm 3:00pm Official Opening of AusBiotech 2012 Plenary Session 1 Commercialisation of Medical Innovation Dr Richard Barker, Director, Centre for Accelerating Medical Innovations, Oxford University Plenary Session 2 Current Perspectives on Global Life Science Investment George Milstein, Managing Director & Co-Head Healthcare Investment, Cowen Investment Bank, USA Official Presentation of the AusBiotech-GSK Student Excellence Awards 2012 Dr Andrew Yeates, Chief Medical Director, GlaxoSmithKline, Australia Sponsored by GlaxoSmithKline Australia 3:00pm 3:30pm Afternoon Tea and Networking with BioIndustry Exhibitors 2 21/09/2012 Draft Program - subject to change

3 3:30pm 5:00pm Development of Biopharmaceuticals in Australia Chair: David Hughes, Chief Executive Officer, BioPharmaceuticals Australia (BPA) Dr Trent Munro, Australian Institute for Bioengineering and Technology (AIBN), University of Queensland Alternative Fuels Geoff Bell, Chief Executive Officer & Chairman, Microbiogen Dr Len Humphreys, Chief Executive Officer, Licella Pty Ltd Further speakers to be confirmed International Investors Unplugged Chair: Hershel Berry, Managing Partner, Blueprint Life Sciences, United States Panellists: Lawrence Gozlan, Chief Executive Officer, Scientia Capital Dr Adam S. Bristol, Portfolio Manager, Aquilo Capital, United States Dr Mike Gerometta, Head of CMC Development, Circadian Technologies Ltd. Marc Goemans, Vice President Marketing & Sales, DSM Biologics Session sponsored by DSM Biologics, Netherlands Caley Castelein M.D.., Managing Director, Kearny Venture Partners, United States Cayce Denton, Associate, TPG Biotechnology, United States Bosun Hau, Portfolio Manager, MVM Life Science Partners, United States Marc Pentopoulos, Portfolio Manager, Symmetry Capital, United States Isai Peimer, Principal, MedImmune Ventures, United States 3 21/09/2012 Draft Program - subject to change

4 6:00pm 7:30pm AusBiotech Victorian Government Official Welcome Reception Showtime Events Centre 61 South Wharf Promenade, South Wharf Janssen Industry Excellence Awards Presented Sponsored by the Government of Victoria Thursday 1 November 8:00am 7:00pm 8:00am 5:00pm 9:00am 10:30am Registration Open Registration, BioIndustry Exhibition & Business Matching Open Including Trade Afternoon (3:30pm-5:00pm) Plenary Session 3 Millis Oration Introduction: Simon Green, Senior Vice President Global Product Development, CSL New Medicines How Do We Get Them & How Do We Pay for Them? Millis Orator: Dr Alan Robertson, Chief Executive Officer, Pharmaxis Plenary Session 4 Translating Discovery into Products & Services Plenary Speaker: Janssen Cilag Plenary Speaker 4 21/09/2012 Draft Program - subject to change

5 Plenary Session 5 Presentation title to be confirmed Plenary speaker: Dr Susan Windham-Bannister, President & Chief Executive Officer, Massachusetts Life Sciences Center (MLSC) 10.30am 11.00am 11:00am 12:30pm Morning Tea and Networking with Exhibitors Commercialising Stem Cell Therapies Chair: Prof Martin Pera, Director, Stem Cells Australia Dr Michael May, Chief Executive Officer, Centre for Commercialisation of Regenerative Medicine, Toronto, Canada Dr Terry Thomas, Senior VP, Research and Development, Stemcell Technologies, Vancouver Canada Prof Paul Simmions, Executive Vice President Corporate Research & Product Development, Mesoblast Big Pharma- The Road Ahead Chair: Glenn Cross, Chief Operating Officer, AusBiotech Greg Wiederrecht, Vice President and Head of the External Scientific Affairs, MSD Mark Fladrich, Managing Director Australia & New Zealand, AstraZeneca Maintaining Coexistence in the Australian Seed and Grain Value Chain David Hudson, GM & CEO, SGA Solutions Pty Further speaker details coming soon Session sponsored by The Agricultural Biotechnology Council of Australia Session sponsored by the Canadian Trade Commission Kathy Connell, Biotechnology Alliance Manager, Janssen-Cilag 12:30pm 1:30pm 12:30pm 1:30pm 1:30pm 2:30pm Lunch and Networking with BioIndustry Exhibitors AusBiotech AGM AusBiotech Board Meeting 5 21/09/2012 Draft Program - subject to change

6 1:30pm 3:00pm Australia Succeeds Chair: Dr Anna Lavelle, Chief Executive Officer, AusBiotech Greg Collier, Managing Director, Barwon Biotechnology Pty Ltd Further speaker details coming soon Changing Strategies in Tech Transfer Chair: Dr Carrie Hillyard, Chair of UniQuest Dr Kevin Cullen, Chief Executive Officer, UNSW David Henderson, Managing Director, UniQuest Julian Clark, Head Business Development, Walter & Eliza Hall Institute of Medical Research Superannuation - Non-Dilutive Capital A Plan for the Future Chair: Glenn Cross, Chief Operating Officer, AusBiotech Andrea Slattery, Chief Executive Officer, Self- Managed Super Fund Professionals Association of Australia Ltd (SMSF) Lawrence Gozlan, Chief Executive Officer, Scientia Capital Brigitte Smith, Managing Director, GBS Venture Partners Pty Ltd Gordon Nobel, Director Advocacy & Policy Strategy, Association of Super Funds (ASFA) 3:00pm 3:30pm Afternoon Tea & Networking with BioIndustry Exhibitors 6 21/09/2012 Draft Program - subject to change

7 3:30pm 5:00pm Recent Developments in Australian & US Patent Law & their Impact on the Biotechnology Industry Chair: Dr Jenny Petering, Partner, FB Rice Funding for Early Stage Chair: Leigh Farrell, Vice President Business Development, Biota Holdings Ltd CEO Leaders Forum: Greatest Challenges Facing the Sector Over the Next 5 Years Chair: Mr Jeremy Curnock-Cook, Managing Director, Octa Phillip Dr Lisa A. Haile, J.D., Partner, Life Sciences Practice DLA Piper United States Dr Gilbert Mintz, Managing Director, National Multiple Sclerosis Society, USA Dr Jackie Fairley, CEO, Starpharma Holdings Pty Ltd Nicholas Tyacke, Partner, Life Sciences Practice DLA Piper Dean Moss, General Manager - Life Sciences, Uniquest Pty Ltd. Dr Deborah Rathjen, CEO & Managing Director, Bionomics Ltd Helen Mutimer, Director of Intellectual Property- Patents and Licensing, R&D Division, CSL Limited Dr Mel Billingsley, President & Chief Executive Officer, Life Sciences Greenhouse of Central PA, USA Dr Peter French, Chief Executive Officer, Benitec Biopharma 5:00pm-6:00pm 6:00pm 7:00pm Session sponsored by DLA Piper Australia UKTI Cocktails at Booth in BioIndustry Exhibition Hall (by Invitation only) Event Partner Reception Chris Nave, Managing Director, Brandon Capital 7 21/09/2012 Draft Program - subject to change

8 7:00pm 11:00pm AusBiotech - CSL Official Conference Dinner Keynote address Simon Green, Senior Vice President Global Product Development, CSL, Friday 2 November 8:00am 5:30pm 8:00am 2:00pm 8:00am 5:30pm Australasian Life Sciences & Investment Summit (by invitation only separate registration required) BioIndustry Exhibition & Business Matching Open AusFoodtech 9:00am 10:30am Doing Business in India Clinical Trials VLSCI Life Sciences Computation By 2015 the Indian pharmaceutical market is expected to be worth $20B with 10% of this coming from novel therapeutics. This session will provide you with knowledge and experience of doing biotechnology / pharmaceutical business in India. Session details coming soon Assoc Prof Andrew Lonie, Head of Life Sciences Computation Centre, VLSCI, Melbourne, Australia. Prof Gary Egan, Director of Monash Biomedical Imaging (MB), Monash University, Clayton, Australia Session sponsored by The Government of Victoria Dr Michael Kuiper, Molecular Modelling Scientist, VLSCI, Melbourne, Australia 10:30am 11:00am Morning Tea and Networking with BioIndustry Exhibitors 8 21/09/2012 Draft Program - subject to change

9 11:00am 12:30pm Realising Value: Bridging the Gap Between Science & Commercial Success Chair: Dr Colin White, President, Invetech PART 1: Core Science Concept /idea, science and technologies with commercial potential. Building a business case and lessons learned PART 2: Product Development David James, Director Biomedical Instruments & Devices, Invetech PART 3: Route-to-market Leigh Farrell, Vice President Business Development, Biota Holdings Ltd Market Access: Risk Sharing (Health Technology Assessment, Value Based Pricing) Goes Global- Implications for Australian Biotech Chair: Robert Salt, Founder & Principal, SALT Global Consulting LLC Gary Phillips, Chief Operating Officer, Pharmaxis Further session details to be confirmed Managing Risks in Clinical Trials Chair: George Gilmour, Senior Underwriter Technology Insurance Specialty Travis McIntosh, Assistant Vice President, Life Science Specialist, Asia Pacific Zone, Chubb Insurance Company of Australia Limited Lisa Nelson, General Manager & Chief Executive Officer, Nucleus Network Dr Michelle Miller, Chief Executive Officer & Managing Director, Biotron Limited Session sponsored by Chubb Australia Ltd Session sponsored by Invetech 12:30pm 2:00pm Closing Reception 9 21/09/2012 Draft Program - subject to change

10 2:30pm 4:00pm Public Forum: Re-seeing the Future How Technology May Restore Vision Loss Level 2, Melbourne Convention Centre Moderator: Sally Cockburn, 3AW Dr Feelgood Panellists: Prof Jonathan Crowston, Head Glaucoma Research Unit & Managing Director, CERA Prof Robyn Guymer, Head Macular Research Unit, CERA & Bionic Vision Alice Pebay, Head Neuroregeneration Unit, CER Megan Munsie Policy & Outreach Manager and Head of Eduation, Law & Community Awareness Unit, Stem Cells Australia Maryanne Diamond, GM International & Stakeholder Relations, Vision Australia 10 21/09/2012 Draft Program - subject to change

AusBiotech presents BioPro Professional Development BioPro Course: The Secret Sauce of Deal Making Sponsored by the Government of Victoria

Monday 29 October 9:00am 5:00pm AusBiotech presents BioPro Professional Development BioPro Course: The Secret Sauce of Deal Making Sponsored by the Government of Victoria Tuesday 30 October 9:00am 5:00pm